$14.92
3M Ago | 1M Ago | Current | |
Buy | 14 | 13 | 13 |
Outperform | 6 | 6 | 6 |
Hold | 6 | 7 | 6 |
Underperform | 0 | 0 | 0 |
Sell | 1 | 1 | 1 |
The latest share price target for Acadia Pharmaceuticals Inc. (ACAD) is $25.28, offered by 26 analysts offering 12-month price forecasts.
Acadia Pharmaceuticals Inc. (ACAD) has a maximum of 0.69 upside potential, based on 26 analysts offering 12-month price forecasts.
Based on 26 analysts tracking and researching Acadia Pharmaceuticals Inc. (ACAD), 73.08% have a buy recommendation. Remaining 26.92% have either sell or hold recommendations.
The latest share price of Acadia Pharmaceuticals Inc. (ACAD) is $14.92 as of 15/10/2024.
19 of total 26 analysts offering stock ratings for Acadia Pharmaceuticals Inc. ACAD have recommended buy rating.